跳至主要内容
临床试验/NCT06626490
NCT06626490招募中不适用

Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants

Aesculap AG2 个研究点 分布在 2 个国家目标入组 120 人开始时间: 2026年4月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Aesculap AG
入组人数
120
试验地点
2
主要终点
Functional outcome of the hip revision surgery

研究概览

简要总结

The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem. The study is an observational post-market clinical follow-up study, and the study sites chose the stem variant depending on their own routine and indication.

详细描述

Generally, the advantage of the Prevision implant family is that all implant variants can be implanted with basically the same instrumentation, which makes it easier to switch to another variant. All implant variants will be available at the study sites and switching between the variants in the study will be encouraged.

The aim of the study is to prove the non-inferiority of the OHS functional outcome after two years to the predecessor implant generation, and comparable revision hip stems. In addition, the patient groups treated with the different variants, and outcome of these subgroups will be descriptively compared.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Revision hip arthroplasty patients treated with a Prevision hip stem
  • Written patient informed consent
  • Patients are able to attend at follow-up examinations

排除标准

  • Patients < 18 years at surgery
  • Pregnancy at implantation
  • Patients held in a custodial setting
  • Patients in a relationship of dependence on the sponsor, the clinic or the investigator

结局指标

主要结局

Functional outcome of the hip revision surgery

时间窗: after two years

Oxford Hip Score:The Oxford Hip Score (OHS) is a joint-specific, patient-reported outcome measure designed to assess disability in patients undergoing total hip replacement (THR)

次要结局

  • Kaplan-Meier survival(after two years)
  • EQ-5D-5L Quality of Life(visits after 2 and 5 years)
  • Complications(visits after 2 and 5 years)
  • Patient satisfaction(visits after 2 and 5 years)
  • Pain (VAS Score)(visits after 2 and 5 years)
  • Radiology: Hip stem subsidence(visits after 2 and 5 years)
  • Qualitative radiologic assessment(visits after 2 and 5 years)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验